TNFSF10 and breast cancer: To determine whether the combination of DUB inhibition and TRAIL can regulate the cellular response to TRAIL in resistant cell lines, we assessed total protein ubiquitination in TRAIL-resistant pancreatic (Panc1) and breast cancer (T47D) cells in the presence of a DUB (G9) inhibitor.